Abstract 24. Melanoma: How Much Does Time To Treatment Matter?

Abstract

RESULTS: Patients with longer times to treat tended to be male, use Medicare, have melanoma on the head and neck and have a higher melanoma stage. Younger age at diagnosis, lack of comorbidities, and lower melanoma stage favorably affected survival. After multivariate adjustment, there was no difference between patients treated in 1–30 days, 31–60 (HR 1.02… (More)

Topics

Cite this paper

@inproceedings{Conic2017Abstract2M, title={Abstract 24. Melanoma: How Much Does Time To Treatment Matter?}, author={Ruzica Z. Conic and Claudia I Cabrera and Alok A. Khorana and Brian R. Gastman}, year={2017} }